-
Pharma-owned channels are highly valued for patient offerings in EU5
Find out what are the top needs of EU5 physicians from pharma owned channels and how to deepen HCP engagement across pharma channels with the help of heatmap messaging analysis. Click on the...
-
Oncology Trends: Evolving Payer, Provider Landscape Aims for Greater Control Over Physicians
Consolidation and integration of payers/PBMs and of oncology providers means greater standardization of care, more providers at-risk for costs, and better coordination of care. The increasing cost-...
-
Greater Accuracy in Market Sizing
Greater Accuracy in Pharma Market Sizing Epidemiology + Real-World Evidence: The case for collaborative, agile research
-
Value-Based Contracting: What's Driving Value-Based Contracting in Medtech?
Value-based contracting is an increasingly important topic for medtech companies. DRG Partner Adrienne Lovink reviews the top 3 reasons we’re seeing this type of agreement grow in today’s...
-
Value-Based Contracting: Who are The Key Stakeholders in Value-Based Contracts?
DRG Partner Adrienne Lovink discusses the top stakeholders in value-based contracting in the medtech industry, and key trends to watch as this trend continues. Transcription: When a med device...
-
Value-Based Contracting: How Prevalent are Value-Based Contracts Today?
Medtech value-based contracting is still in its early stages. DRG Partner Adrienne Lovink discusses the state of this trend today, and key challenges stakeholders are facing. Transcription: I...
-
Value-Based Contracting: Where is The Future Heading?
DRG Partner Adrienne Lovink discusses the future of value-based contracting in the medtech industry. She lays out 3 key macrotrends that indicate we’ll see more types of these agreements in...
-
Value-Based Contracting: Which Medtech Markets will See The Most Growth?
As value-based contracting starts to pick up steam in medtech, these types of agreements will be more common in certain medtech markets. DRG Partner Adrienne Lovink outlines the 3 top...
-
Value-Based Contracting: What's The Impact on Medtech Companies?
Value-based contracting is prompting medtech companies to fundamentally change their operating models. DRG Partner Adrienne Lovink reviews 3 key ways that manufacturers will need to evolve to...
A global consultancy and training agency providing market leading product & portfolio strategy, health economic outcomes research & evidence generation, value communication and training services across the life science industry.
We partner with both the biopharmaceutical and medical technology industry to support commercialization & patient access across a variety of functions including: R&D, commercial strategy, HEOR, market access, new product planning, marketing, data insights & analytics, business development and channel & segment customer engagement.
